Building the DREAM interactome

Science China Life Sciences

Volumn 54, Issue 8, 2011, Pages 786-792

  Rivas, Marcos ^a   Villar, Diego ^a   González, Paz ^a   Dopazo, X M ^a   Mellstrom, Britt ^a   Naranjo, J R ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

calsenilin; KChIP3; protein protein interaction

Indexed keywords

DNA; KV CHANNEL INTERACTING PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; SEQUENCE ALIGNMENT; THYROID GLAND; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; DNA; GENE EXPRESSION REGULATION; HUMANS; KV CHANNEL-INTERACTING PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SEQUENCE ALIGNMENT; THYROID GLAND; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 79960646525     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4196-4     Document Type: Review

References (36)

1. Carrion A M, Mellstrom B, Naranjo J R. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol, 1998, 18: 6921-6929.
2. 2+-regulated transcriptional repressor. Nature, 1999, 398: 80-84.
3. An W F, Bowlby M R, Betty M, et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature, 2000, 403: 553-556.
4. Link W A, Ledo F, Torres B, et al. Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci, 2004, 24: 5346-5355.
5. Buxbaum J D, Choi E K, Luo Y, et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med, 1998, 4: 1177-1181.
6. 2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev, 2008, 88: 421-449.
7. 2+-dependent block of CREB-CBP transcription by repressor DREAM. EMBO J, 2002, 21: 4583-4592.
8. Wu L J, Mellstrom B, Wang H, et al. DREAM (Downstream Regulatory Element Antagonist Modulator) contributes to synaptic depression and contextual fear memory. Mol Brain, 2010, 3: 3.
9. Rivas M, Mellstrom B, Torres B, et al. The DREAM protein is associated with thyroid enlargement and nodular development. Mol Endocrinol, 2009, 23: 862-870.
10. Craig T A, Benson L M, Venyaminov S Y, et al. The metal-binding properties of DREAM: evidence for calcium-mediated changes in DREAM structure. J Biol Chem, 2002, 277: 10955-10966.
11. Osawa M, Tong K I, Lilliehook C, et al. Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3. J Biol Chem, 2001, 276: 41005-41013.
12. Naranjo J R, Mellstrom B, Achaval M, et al. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron, 1991, 6: 607-617.
13. Wagner J J, Terman G W, Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature, 1993, 363: 451-454.
14. Ledo F, Carrion A M, Link W A, et al. DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol, 2000, 20: 9120-9126.
15. Rivas M, Mellstrom B, Naranjo J R, et al. Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin gene expression. J Biol Chem, 2004, 279: 33114-33122.
16. Zaidi N F, Kuplast K G, Washicosky K J, et al. Calsenilin interacts with transcriptional co-repressor C-terminal binding protein(s). J Neurochem, 2006, 98: 1290-1301.
17. Leissring M A, Yamasaki T R, Wasco W, et al. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc Natl Acad Sci USA, 2000, 97: 8590-8593.
18. Lilliehook C, Bozdagi O, Yao J, et al. Altered Abeta formation and long-term potentiation in a calsenilin knock-out. J Neurosci, 2003, 23: 9097-9106.
19. Jo D G, Lee J Y, Hong Y M, et al. Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure. J Neurochem, 2004, 88: 604-611.
20. Jin J K, Choi J K, Wasco W, et al. Expression of calsenilin in neurons and astrocytes in the Alzheimer's disease brain. Neuroreport, 2005, 16: 451-455.
21. 2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem, 2005, 94: 1711-1718.
22. Quintero C A, Valdez-Taubas J, Ferrari M L, et al. Calsenilin and CALP interact with the cytoplasmic tail of UDP-Gal: GA2/GM2/GD2 beta-1, 3-galactosyltransferase. Biochem J, 2008, 412: 19-26.
23. Parker D, Ferreri K, Nakajima T, et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol, 1996, 16: 694-703.
24. Le Douarin B, Nielsen A L, Garnier J M, et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J, 1996, 15: 6701-6715.
25. Scsucova S, Palacios D, Savignac M, et al. The repressor DREAM acts as a transcriptional activator on Vitamin D and retinoic acid response elements. Nucleic Acids Res, 2005, 33: 2269-2279.
26. Lusin J D, Vanarotti M, Li C, et al. NMR structure of DREAM: Implications for Ca(2+)-dependent DNA binding and protein dimerization. Biochemistry, 2008, 47: 2252-2264.
27. Iacovelli L, Sallese M, Mariggio S, et al. Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J, 1999, 13: 1-8.
28. Ruiz-Gomez A, Mellstrom B, Tornero D, et al. G protein-coupled receptor kinase 2-mediated phosphorylation of downstream regulatory element antagonist modulator regulates membrane trafficking of Kv4. 2 potassium channel. J Biol Chem, 2007, 282: 1205-1215.
29. Palczewska M, Casafont I, Ghimire K, et al. Sumoylation regulates nuclear localization of repressor DREAM. Biochim Biophys Acta, 2010, 1813: 1050-1058.
30. Rivas M, Aurrekoetxea K, Mellstrom B, et al. Redox signaling regulates transcriptional activity of the Ca(2+)-dependent repressor DREAM. Antioxid Redox Signal, 2010, 14: 1237-1243.
31. Zhang Y, Su P, Liang P, et al. The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit. J Neurosci, 2010, 30: 7575-7586.
32. Anderson D, Mehaffey W H, Iftinca M, et al. Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes. Nat Neurosci, 2010, 13: 333-337.
33. Thomsen M B, Wang C, Ozgen N, et al. Accessory subunit KChIP2 modulates the cardiac L-type calcium current. Circ Res, 2009, 104: 1382-1389.
34. Rual J F, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature, 2005, 437: 1173-1178.
35. Lin Y L, Wu P F, Wu T T, et al. KChIP3: a binding protein for Taiwan banded krait beta-bungarotoxin. Toxicon, 2006, 47: 265-270.
36. 2+ signalling. Nat Rev Neurosci, 2007, 8: 182-193.